{"id":"abrocitinib-suspension-f2","rwe":[],"tags":[],"safety":{"drugInteractions":[{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Live vaccines","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Bacillus Calmette-Guérin (BCG) vaccine","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Other vaccines","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Interferon-alpha","action":"Monitor","effect":"Increased risk of hepatotoxicity"},{"drug":"Interferon-beta","action":"Monitor","effect":"Increased risk of hepatotoxicity"},{"drug":"Interferon-gamma","action":"Monitor","effect":"Increased risk of hepatotoxicity"},{"drug":"Live attenuated vaccines","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live attenuated)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, attenuated)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated and/or attenuated)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, and/or attenuated)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"},{"drug":"Vaccines (live, inactivated, attenuated, or toxoid; inactivated and/or live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid; live, attenuated, or toxoid)","action":"Avoid","effect":"Decreased vaccine efficacy"}],"commonSideEffects":[],"contraindications":["Do not start CIBINQO if you: - are under 12 years of age\n- intend to use it for a condition for which it was not prescribed - have any kind of infection unless your healthcare provider tells you it is okay - have any signs and symptoms of blood clots - have lymphocyte, neutrophil, red blood cell, or platelet counts that are too low - take medicines that prevent blood clots (antiplatelet medicines), except for low-dose aspirin up to a dose of 81 mg each day during the first 3 months of CIBINQO treatment - are taking certain other medicines\n- are breastfeeding or plan to breastfeed\n- have severe kidney problems - have severe liver problems\n- recently received a live vaccine"],"specialPopulations":{"Pregnancy":"Pregnant women and their offspring","Geriatric use":"text","Paediatric use":"0+ years","Renal impairment":"text","Hepatic impairment":"text"}},"trials":[],"_chembl":null,"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=abrocitinib-suspension-f2","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:57:31.590386+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:57:37.426677+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:57:31.662078+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=abrocitinib-suspension-f2","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:57:38.323005+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Tyrosine-protein kinase JAK1 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:57:39.406730+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3655081/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:57:39.074136+00:00"}},"allNames":"abrocitinib suspension f2","offLabel":[],"timeline":[],"_dailymed":null,"aiSummary":"Abrocitinib Suspension F2, developed by Pfizer Inc., is a marketed drug for moderate to severe atopic dermatitis. It has generated $21.2B in revenue. The mechanism of action is not specified on Wikipedia. Abrocitinib Suspension F2 has 1 trial and 0 publications. It is a significant commercial product. There are no pipeline developments mentioned.","brandName":"Abrocitinib Suspension F2","ecosystem":[],"isGeneric":true,"mechanism":{"target":"unknown","novelty":"unknown","modality":"unknown","drugClass":"unknown","explanation":"","oneSentence":"","technicalDetail":"The exact mechanism of action of Abrocitinib Suspension F2 is unknown, making it difficult to provide detailed technical information. However, it is known to be used for treating moderate to severe atopic dermatitis."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"_scrapedAt":"2026-03-27T23:28:56.645Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"revenueYear":2025,"annualCostUS":"$80,000/yr","annualRevenue":284,"genericStatus":"Generic — off-patent","revenueSource":"SEC 8-K Pfizer (2026-02-03)","currentRevenue":"$21.2B","revenueCurrency":"USD","peakSalesEstimate":"$21.2B","revenueConfidence":"verified (SEC filing)","revenueExtractedAt":"2026-04-01T10:48:50.281182","revenueExtractedBy":"revenue-sec"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=abrocitinib-suspension-f2","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=abrocitinib-suspension-f2","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:57:40.779017+00:00","fieldsConflicting":2,"overallConfidence":0.8},"_whoChecked":true,"biosimilars":[],"competitors":[{"name":"Dupixent (dupilumab)","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis, asthma, and other conditions"},{"name":"Ebglyss (lebrikizumab)","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"},{"name":"Triamcinolone topical","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"},{"name":"Clobetasol topical","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"},{"name":"Tacrolimus topical","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"},{"name":"Dupilumab","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"},{"name":"Betamethasone topical","company":"Not specified","advantage":"Alternative treatment for atopic dermatitis"}],"genericName":"abrocitinib-suspension-f2","indications":{"approved":[{"name":"Moderate to severe atopic dermatitis","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04903093","phase":"PHASE1","title":"A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-06-04","conditions":"Healthy Volunteers","enrollment":19}],"_emaApprovals":[{"date":"","name":"Abrocitinib Suspension F2","status":"Authorised","regulator":"EMA"}],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"molecularData":{"oral":true,"chemblId":"CHEMBL3655081","moleculeType":"Small molecule","molecularWeight":"323.42"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL3655081"},"formularyStatus":[],"_approvalHistory":[],"_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Immunology"],"_revenueScrapedAt":"2026-04-01 09:48:50.313664+00","biosimilarFilings":[],"recentPublications":[],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"companionDiagnostics":[],"_genericFilersChecked":true,"genericManufacturerList":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"unknown","firstApprovalDate":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"pricingByCountry":[{"country_code":"US","currency":"USD","price_amount":"80000.00","price_per":"year","price_type":"annual_list","annual_cost_usd":null,"reimbursement_status":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:57:40.779017+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}